Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
232.69
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Charles River Laboratories Intl
< Previous
1
2
3
4
5
6
7
Next >
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
April 22, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
April 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
April 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
April 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
April 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River to Perform Plasmid Production for Ship of Theseus
April 04, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
April 01, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
March 27, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
March 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
March 14, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
February 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
February 20, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
January 29, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
January 24, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
January 23, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
January 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
January 08, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
December 18, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
December 12, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
November 28, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Evercore ISI Investor Conference
November 27, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
November 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
November 13, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023
November 09, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Third-Quarter 2023 Results
November 08, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business
October 19, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.